Medical Morphine Market: The Gold Standard Opioid for Severe Pain Management and End-of-Life Care
The Medical Morphine Market centers on one of the oldest and most established opioid analgesics, which remains the benchmark for treating severe acute and chronic pain globally. Morphine is a phenanthrene opioid receptor agonist that primarily activates the -opioid receptor in the central nervous system, leading to its primary effects of analgesia and sedation. Its therapeutic application is critical for managing intense pain associated with conditions like cancer, myocardial infarction, and trauma. A 2016 Cochrane review confirmed its effectiveness in relieving cancer pain, which is a significant driver in the medical market, especially as the population ages and cancer prevalence increases.